联环药业(600513.SH)：苯磺酸氨氯地平片获得《药品注册证书》

Group 1 - The core point of the article is that Lianhuan Pharmaceutical (600513.SH) announced that its subsidiary, Xinxiang Changle Pharmaceutical Co., Ltd., has received the drug registration certificate from the National Medical Products Administration for Amlodipine Besylate Tablets, a commonly used medication for regulating vascular pressure [1] Group 2 - The drug Amlodipine Besylate Tablets is recognized for its role in managing blood vessel pressure, indicating its significance in the pharmaceutical market [1]